Tamada, Satoshi
Nozawa, Masahiro
Ohba, Kojiro
Mizuno, Ryuichi
Takamoto, Atsushi
Ohe, Chisato
Yoshimoto, Takuya
Nakagawa, Yuki
Fukuyama, Tamaki
Matsubara, Nobuaki
Kimura, Go
Tomita, Yoshihiko
Nonomura, Norio
Eto, Masatoshi
Funding for this research was provided by:
Chugai Pharmaceutical Co Ltd
Article History
Received: 22 June 2022
Accepted: 12 October 2022
First Online: 19 December 2022
Declarations
:
: S.T. received research funding from Chugai and honoraria from Merck Biopharma, Merck Sharp & Dohme, Pfizer, and Takeda. M.N. received honoraria from Janssen, Merck Sharp & Dohme, Sanofi and Takeda. R.M. received honoraria from Bristol Myers Squibb, Novartis, Ono Pharmaceutical and Pfizer. C.O. received honoraria from AstraZeneca, Chugai Pharmaceutical, and Janssen; travel, accommodation, or other expenses from AstraZeneca and Chugai Pharmaceutical; and research funding from Chugai Pharmaceutical. N.M. served as an advisor or consultant for Janssen and Sanofi and received research funding from Bayer, Chugai, Janssen, Eli Lilly, PRA health science, AstraZeneca, Amgen, Taiho Eisai, Pfizer, Astellas, and Merck Sharp & Dohme. G.K. received honoraria from AstraZeneca, Bayer, Bristol Myers Squibb, Chugai Pharmaceutical, Janssen, Merck Sharp & Dohme, Novartis, Ono Pharmaceutical, Pfizer, and Takeda and research funding from AstraZeneca, Bayer, Bristol Myers Squibb, Chugai Pharmaceutical, Janssen, Merck Sharp & Dohme, Ono Pharmaceutical, and Takeda. Y.T. received honoraria from Astellas, Bristol Myers Squibb, Chugai Pharmaceutical, Novartis, Ono Pharmaceutical, and Pfizer and research funding from Astellas Pharma, Chugai Pharmaceutical, Ono Pharmaceutical, Pfizer, and Takeda. N.N. received honoraria from Bristol Myers Squibb, Chugai Pharmaceutical, Novartis, Ono Pharmaceutical, and Pfizer. M.E. received honoraria from Bristol Myers Squibb, Chugai Pharmaceutical, Janssen, Merck Sharp & Dohme, Novartis, Ono Pharmaceutical, Pfizer, and Takeda and research funding from Astellas Pharma, Bayer, Kissei Pharmaceutical, Ono Pharmaceutical, Sanofi, and Takeda. T.Y., Y.N., and T.F. are employees of Chugai Pharmaceutical. K.O. and A.T. declare no competing interests.
: This manuscript does not include any person’s individual data.